Identify the care-manager role without enlarging it

The membership FAQ describes a care manager helping with history, appointment logistics, insurance questions, finding test sites and obtaining medical records. It also says clinicians can prescribe and order further tests when needed. These statements make Paloma relevant to a patient bringing an existing thyroid prescription into a new practice.

Administrative support is not itself a clinical decision or proof that every outside record will arrive. The useful question is how the care manager and treating clinician divide responsibility. PlushCare’s review provides a different example, with public instructions for submitting documents before a video visit rather than the same dedicated-care-manager description.

Read the annual charge separately from the visit

Paloma’s pricing page presents Hormone Rebalance at $20 per month billed annually, or $240 per year. The same page says membership renews automatically each year. It lists $60 cash physician visits or an applicable insurance copay. The membership FAQ says insurance does not pay the membership fee; medicine is not included in the plan’s stated cost.

The page contains other program tiers and older $55/$65 package snippets, while the FAQ retains older $96/$192 membership wording in a relocation answer. These do not establish alternative current thyroid prices. The $240 annual description is repeated in the current membership explanation, but the actual selected agreement and coverage still need confirmation. No combined annual treatment total is verified here.

Keep cancellation and appointment rules distinct

The membership FAQ says annual access continues through the paid term after cancellation. For memberships bought on or after July 15, 2025, it describes no prorated refund after services are used, with a refund less a $15 administrative fee when canceled within seven days and before the first physician visit. It separately promises a full refund if the practice finds the person ineligible.

Appointment wording is less consistent: one answer permits cancellation or rescheduling at least four hours ahead, while its instructions say at least 24 hours. It lists a $60 no-show fee, including arrival over ten minutes late. These terms were not tested; clarification should come from the practice rather than selecting whichever deadline appears easier.

Check location and the limits of messaging

The pricing page and membership FAQ publish different state lists; the FAQ includes New Jersey and New York where the pricing list does not. Neither list is a verified appointment in a particular state. Moving or changing insurance may require a fresh access check.

Paloma describes unlimited team messaging and an expected response within 72 hours, usually sooner. It explicitly says messaging is not emergency care and that complex questions may require an appointment. Lemonaid’s review illustrates a more restricted refill offer. These different access models should not be reduced to an assumption that all online thyroid services offer the same ongoing contact.

Follow a clinical decision to the pharmacy

The pricing-page FAQ says the Paloma physician communicates medication changes to the chosen pharmacy and describes pickup as often possible the same day. That is a provider statement, not verified dispensing performance. It does not establish a particular levothyroxine manufacturer, stock level or insurance outcome.

The manufacturer-change guide concerns the actual pharmacy record. MedlinePlus likewise places questions about medicine names and brand changes with the doctor or pharmacist. Paloma’s broader language about considering medication options does not establish that changing products is necessary or that a requested formulation will be prescribed for an individual.

Use coordinated records without importing promotional conclusions

Paloma’s membership description includes obtaining records and arranging external referrals. These are useful questions when a previous clinician and a new thyroid practice both hold parts of the history. They do not show that every laboratory result has already been reviewed or that a supplement promoted on the site belongs in a patient’s treatment.

The ATA source discusses monitoring and factors that can affect thyroid care. Our biotin questions and food and supplement questions keep those matters within professional discussion. This review does not adopt Paloma’s testimonials or comparative claims about typical practices as evidence of superior outcomes.

Evaluate continuity as a set of responsibilities

The documented care-coordination model is Paloma’s most distinctive feature for this purpose. The patient can ask who obtains an earlier report, who interprets it, who sends any prescription and who responds when the pharmacy needs clarification. None of these steps follows automatically from buying membership.

The remaining uncertainty includes state access, conflicting administrative text, the selected agreement and the complete visit, testing and medicine costs. Paloma is therefore a provider to assess through its specific coordination offer, not a verified solution for every existing prescription. Medical suitability, treatment selection and changes remain matters for the treating professionals, while this review makes the public service boundaries easier to compare.

A care manager’s support may help arrange communication, but it should not be represented as a guarantee that another practice will release or review a record by a particular date.